임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 1/2상모집 예정· Myeloma MultipleEtenta-Isa-VRd in Newly Diagnosed High-Risk Multiple Myeloma
협력: 애브비, 사노피
- 1/2상모집 예정· Acute Lymphoblastic LeukemiaHEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
협력: 애브비, 아스트라제네카
- 1/2상모집 예정· JAK1 GOFUpadacitinib in Treatment of JAK/STAT Pathway Disorders With Activating Mutations
협력: 애브비
- 4상모집 예정· UC - Ulcerative ColitisUpadacitinib in Patients Hospitalized With Acute Severe Ulcerative Colitis
협력: 애브비
- 단계 미표기모집 예정· Folate Receptor-Alpha Positive Platinum-Resistant High-Grade Serous Epithelial Ovarian CancerA Study to Evaluate Adverse Events and Change in Disease Activity of Mirvetuximab Soravtansine-gynx in Adults With Folate Receptor-Alpha Positive, Platinum-Resistant Ovarian Cancer in a Real-World Setting
리드: 애브비
- 1상모집 예정· Healthy VolunteerStudy to Assess How Different Oral Formulations of Ubrogepant Move Through the Body in Healthy Adult Participants
리드: 애브비
- 1상모집 예정· Healthy VolunteerA Study to Evaluate How Multiple Doses of Itraconazole Interacts With Nacresertib in Healthy Adult Participants
리드: 애브비
- 2상모집 중· Upper Limb Essential TremorStudy of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Essential Tremor
리드: 애브비
- 2상모집 중· Chronic Lymphocytic Leukemia (CLL)Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab
리드: 아스트라제네카 · 협력: 애브비, 로슈
- 단계 미표기모집 예정· Diabetic Macular EdemaA Study to Assess the Use of Artificial Intellignce to Predict Eye Treatment Changes in Adult Participants With Diabetic Macular Edema
리드: 애브비
- 1상모집 중단 (진행 중)· Healthy VolunteersStudy to Assess Adverse Events and How Oral Emraclidine Moves Through the Body of Adult Healthy Volunteers
리드: 애브비
- 1상모집 중· Healthy VolunteersA Phase 1 Study to Assess the Effect of Itraconazole on ABBV-722 in Healthy Adult Participants
리드: 애브비
- 1상모집 중단 (진행 중)· Healthy VolunteerA Mass Balance Study of Oral [14C] ABBV-932 in Healthy Adult Male Participants
리드: 애브비
- 2/3상모집 중· Metastatic Pancreatic Ductal AdenocarcinomaA Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants With First-Line Metastatic Pancreatic Ductal Adenocarcinoma
리드: 애브비
- 1상모집 중단 (진행 중)· Healthy VolunteerA Phase 1 Study to Assess the Effect of ABBV-722 on Ethinyl Estradiol and Levonorgestrel Drug Levels in Healthy Adult Female Participants
리드: 애브비
- 단계 미표기모집 중· Hepatitis C Virus (HCV)Study of Glecaprevir/Pibrentasvir to Assess Safety Through Real-World Data
리드: 애브비
- 2상모집 중· Lung Non-Small Cell CarcinomaTelisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer
협력: 애브비
- 1상모집 중단 (진행 중)· Healthy VolunteerA Study to Assess How the Body Absorbs ABBV-8736 Subcutaneous Injections Relative to Intravenous Injections in Adult Healthy Volunteers
리드: 애브비
- 2상모집 중· Idiopathic Pulmonary FibrosisStudy of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
리드: 애브비
- 2/3상모집 중· Multiple MyelomaA Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
리드: 애브비
- 2상모집 중· Major Depressive DisorderA Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
리드: 애브비
- 1상모집 중· Healthy VolunteersA Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.
리드: 애브비
- 2상모집 중· Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Blastic Plasmacytoid Dendritic Cell Neoplasm Patients
협력: 애브비
- 2/3상모집 중· Non-Small Cell Lung CancerA Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
리드: 애브비
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.